Glaukos Completes Patient Enrollment In US 510(k) Pivotal Study Evaluating PRESERFLO MicroShunt In Adult Patients With Primary Open-Angle Glaucoma Who Failed Previous Medical And Surgical Treatment

Loading news article.

Glaukos Completes Patient Enrollment In US 510(k) Pivotal Study Evaluating PRESERFLO MicroShunt In Adult Patients With Primary Open-Angle Glaucoma Who Failed Previous Medical And Surgical Treatment | WAPE

Glaukos Completes Patient Enrollment In US 510(k) Pivotal Study Evaluating PRESERFLO MicroShunt In Adult Patients With Primary Open-Angle Glaucoma Who Failed Previous Medical And Surgical Treatment

Article summary

Related companies

Comments —